Compare VEEE & VTAK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | VEEE | VTAK |
|---|---|---|
| Founded | 1994 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Marine Transportation | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1M | 4.1M |
| IPO Year | 2021 | 2018 |
| Metric | VEEE | VTAK |
|---|---|---|
| Price | $1.72 | $2.25 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 244.0K | 28.7K |
| Earning Date | 11-06-2025 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $13,680,921.00 | $730,000.00 |
| Revenue This Year | N/A | $822.86 |
| Revenue Next Year | N/A | $168.42 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 82.96 |
| 52 Week Low | $1.22 | $1.49 |
| 52 Week High | $9.30 | $15.68 |
| Indicator | VEEE | VTAK |
|---|---|---|
| Relative Strength Index (RSI) | 48.33 | 57.83 |
| Support Level | $1.22 | $1.99 |
| Resistance Level | $1.72 | $2.35 |
| Average True Range (ATR) | 0.20 | 0.12 |
| MACD | -0.01 | 0.04 |
| Stochastic Oscillator | 61.82 | 80.24 |
Twin Vee PowerCats Co is a designer, manufacturer, and marketer of recreational and commercial power boats to use for fishing, diving and water skiing, and commercial activities including transportation, eco-tours, fishing, and diving expeditions. The company offers various boat models, including Twin Vee 400 GFX2 CC, Twin Vee 280 GFX2 CC, and Twin Vee 260 Center Console STX, among others. Its products are marketed under two brands, Twin Vee for its catamarans, or dual-hull vessels, and Aquasport for its V-hull boats. The company sells its boats through a network of independent boat dealers across North America, the Caribbean, and Central America who resell the boats to the end user, Twin Vee customers.
Catheter Precision Inc is engaged in design, manufacture and sale of new and innovative medical technologies primarily focused in the field of cardiac electrophysiology, or EP. The Company's primary product is the View into Ventricular Onset System (VIVO or VIVO System), which is a non-invasive imaging system that offers 3D cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. The VIVO system has achieved a CE Mark allowing it to be commercialized in the European Union and has been placed at several hospitals in Europe. Its newest product, the Surgical Vessel Closing Pressure Device (LockeT), is a suture retention device indicated for wound healing by distributing suture tension.